Stock market recovery! I’d invest £5,000 in FTSE 100 shares like this right now

Stock markets have been tearing back up after their coronavirus plunge. But the situation isn’t as simple as it might at first appear.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Despite recent rises in the stock market, a few sectors remain stuck in the mud and some shares look as if they could move lower still. For example, I’m avoiding banks, such as Lloyds and Barclays. And I’m giving International Consolidated Airlines a miss, along with the rest of the sector.

But as one-time US hedge fund manager Jim Cramer recently mentioned, some sectors look well-placed to thrive in a world featuring Covid-19. So, I’d look for shares in those perky-looking industries, such as Healthcare, IT, Consumer Staples and Drinks.

Healthcare

It’s fair to say the market has recognised the improving prospects of AstraZeneca (LSE: AZN). A significant rerating has occurred in the company’s valuation over past few months and years. Now, with the share price near 8,750p, the forward-looking earnings multiple for 2021 sits just below 22.

However, the firm has been punching out some impressive double- and treble-digit percentage projections for annual increases in earnings. For many years the word among the investing community was AstraZeneca had a lot of potential in its research and development pipeline. And the community was correct. New products are now hitting decent sales figures and driving the re-rating in the shares.

Indeed, the dark days of the firm’s patent-cliff headaches seem but a distant memory now that the stock is flying. But I’d still buy on dips and down-days because I believe the company has a bright future.

I’d also consider cheaper looking alternatives in the FTSE 100, such as GlaxoSmithKline and Hikma Pharmaceuticals.

Information Technology

Integrated accounting, payroll, and payments solutions provider Sage has been busy migrating its customers to cloud-based services. There’s a strong recurring revenue base and the company has long been a consistent cash flow grower.

Meanwhile, engineering, design and information management software provider Aveva has been a darling of the stock market over the past 10 years or so. Indeed, the share has multi-bagged for its shareholders. But with the forward-looking earnings multiple for the trading year to March 2021 above 30, it looks expensive. Nevertheless, this is a strong company and a robust-looking stock. I’d want to own it.

Consumer Staples and Drinks

The consumer staples and drinks sectors are renowned for producing defensive and gently growing companies with stable cash-generating businesses. This is fertile ground for finding firms capable of paying steady and rising dividends.

We can find fast-moving consumer staples providers in giants such as Unilever and Reckitt Benckiser. And I’d widen the definition of what’s considered a consumer staple to include cigarette and tobacco providers such as British American Tobacco and Imperial Brands.

Meanwhile, the FTSE 100 is home to premium branded alcoholic drinks giant Diageo, which has been a great performer over the years. It looks well-placed to shine for its shareholders in the future as well.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Kevin Godbold has no position in any share mentioned. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline and Unilever. The Motley Fool UK has recommended Barclays, Diageo, Imperial Brands, and Lloyds Banking Group. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Petrochemical engineer working at night with digital tablet inside oil and gas refinery plant
Investing Articles

Can the Centrica dividend keep on growing?

Christopher Ruane considers some positive factors that might see continued growth in the Centrica dividend -- as well as some…

Read more »

Smiling family of four enjoying breakfast at sunrise while camping
Investing Articles

How I’d turn my £12,000 of savings into passive income of £1,275 a month

This Fool is considering a strategy that he believes can help him achieve a stable passive income stream with a…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

2 top FTSE 250 investment trusts trading at attractive discounts!

This pair of discounted FTSE 250 trusts appear to be on sale right now. Here's why I'd scoop up their…

Read more »

Smiling young man sitting in cafe and checking messages, with his laptop in front of him.
Investing Articles

3 things that could push the Lloyds share price to 60p and beyond

The Lloyds share price has broken through 50p. Next step 60p? And then what? Here are some thoughts on what…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

£1,000 in Rolls-Royce shares a year ago would be worth this much now

Rolls-Royce shares have posted one of the best stock market gains of the past 12 months. But what might the…

Read more »

Investing Articles

Are HSBC shares a FTSE bargain? Here’s what the charts say!

There are plenty of dirt-cheap FTSE 100 banking stocks for investors to choose from today. Our writer Royston Wild believes…

Read more »

Three signposts pointing in different directions, with 'Buy' 'Sell' and 'Hold' on
Investing Articles

Just released: Share Advisor’s latest ‘Hold’ recommendation [PREMIUM PICKS]

In our Share Advisor newsletter service, we provide buy, sell, and hold guidance for our universe of recommendations.

Read more »

Investing Articles

Investing £5 a day could help me build a second income of £329 a month!

This Fool explains how £5 a day, or one less takeaway coffee, could help her build a monthly second income…

Read more »